Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 12,397,000 | 11,760,000 | 10,816,000 | 10,998,000 | 10,794,000 |
| Cost of Goods | 3,990,000 | 3,401,000 | 3,052,000 | 3,289,000 | 3,619,000 |
| Gross Profit | 8,407,000 | 8,359,000 | 7,764,000 | 7,709,000 | 7,175,000 |
| Operating Expenses | 5,793,000 | 4,901,000 | 4,356,000 | 4,857,000 | 4,511,000 |
| Operating Income | 2,614,000 | 3,458,000 | 3,408,000 | 2,852,000 | 2,664,000 |
| Other Income | -267,000 | -199,000 | -341,000 | -247,000 | 1,000 |
| Pre-tax Income | 2,347,000 | 3,259,000 | 3,067,000 | 2,605,000 | 2,665,000 |
| Income Tax | 440,000 | 615,000 | 205,000 | 827,000 | 707,000 |
| Net Income Continuous | 1,907,000 | 2,644,000 | 2,862,000 | 1,778,000 | 1,958,000 |
| Minority Interests | 6,000 | -26,000 | -53,000 | -49,000 | 8,000 |
| Net Income | $1,901,000 | $2,670,000 | $2,915,000 | $1,827,000 | $1,950,000 |
| EPS Basic Total Ops | 0.74 | 1.04 | 1.13 | 0.70 | 0.73 |
| EPS Basic Continuous Ops | 0.75 | 1.03 | 1.11 | 0.67 | 0.74 |
| EPS Diluted Total Ops | 0.74 | 1.03 | 1.12 | 0.69 | 0.73 |
| EPS Diluted Continuous Ops | 0.74 | 1.02 | 1.10 | 0.67 | 0.73 |
| EBITDA(a) | $3,459,000 | $4,431,000 | $4,306,000 | $3,850,000 | $3,758,000 |